Cargando…
The Treatment of Giant Cell Arteritis in Different Clinical Settings
This paper aims to raise awareness of the different disease courses, comorbidities, and therapy situations in patients with giant cell arteritis (GCA), which require a differentiated approach and often a deviation from current treatment guidelines. With the approval of tocilizumab (TOC), which speci...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353794/ https://www.ncbi.nlm.nih.gov/pubmed/30733723 http://dx.doi.org/10.3389/fimmu.2018.03129 |